{"entity":{"type":"insider","cik":"0001364190","url":"/insider/0001364190","json_url":"/insider/0001364190.json","name":"Hamelin Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":23,"first":"2007-05-25","last":"2011-02-15","span_basis":"filed_date"},"name_variants":[{"name":"Hamelin Paul","source":"filing","n_filings":23,"first_seen":"2007-05-25","last_seen":"2011-02-15"}],"transactions":[{"id":9091773,"accession":"0001181431-11-010543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-010543","line_url":"/filing/0001181431-11-010543#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5371.0,"shares_display":"5,371","price_per_share":9.8896,"price_display":"9.89","price_state":"stated","total_value":53117.0416,"total_display":"53,117.04","total_whole":"53,117","shares_owned_after":124765.0,"shares_owned_after_display":"124,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-14","filed_date":"2011-02-15","scope":"insider"},{"id":7506414,"accession":"0001181431-10-009619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-009619","line_url":"/filing/0001181431-10-009619","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6925.0,"shares_display":"6,925","price_per_share":13.797472476534296,"price_display":"13.80","price_state":"stated","total_value":95547.4969,"total_display":"95,547.50","total_whole":"95,547","shares_owned_after":82949.0,"shares_owned_after_display":"82,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-17","scope":"insider","n_lines":2},{"id":5614680,"accession":"0001181431-09-055987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-055987","line_url":"/filing/0001181431-09-055987#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1981.0,"shares_display":"1,981","price_per_share":13.3648,"price_display":"13.36","price_state":"stated","total_value":26475.6688,"total_display":"26,475.67","total_whole":"26,476","shares_owned_after":89874.0,"shares_owned_after_display":"89,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-09","filed_date":"2009-12-10","scope":"insider"},{"id":5979669,"accession":"0001181431-09-044021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-044021","line_url":"/filing/0001181431-09-044021#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":91855.0,"shares_owned_after_display":"91,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-11","filed_date":"2009-09-15","scope":"insider"},{"id":5643743,"accession":"0001181431-09-027015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-027015","line_url":"/filing/0001181431-09-027015#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1179.0,"shares_display":"1,179","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":6791.04,"total_display":"6,791.04","total_whole":"6,791","shares_owned_after":95855.0,"shares_owned_after_display":"95,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-26","filed_date":"2009-05-26","scope":"insider"},{"id":9211743,"accession":"0000950117-09-000241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-09-000241","line_url":"/filing/0000950117-09-000241#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1777.0,"shares_display":"1,777","price_per_share":5.7693,"price_display":"5.77","price_state":"stated","total_value":10252.0461,"total_display":"10,252.05","total_whole":"10,252","shares_owned_after":97034.0,"shares_owned_after_display":"97,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-23","scope":"insider"},{"id":3672941,"accession":"0000950117-08-001521","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950117-08-001521","line_url":"/filing/0000950117-08-001521","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $0.1 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2515.0,"shares_display":"2,515","price_per_share":4.713101391650099,"price_display":"4.71","price_state":"stated","total_value":11853.45,"total_display":"11,853.45","total_whole":"11,853","shares_owned_after":48876.0,"shares_owned_after_display":"48,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-09","filed_date":"2008-12-10","scope":"insider","n_lines":2},{"id":3649335,"accession":"0001230295-08-000437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001230295-08-000437","line_url":"/filing/0001230295-08-000437#line-3","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1231.0,"shares_display":"1,231","price_per_share":25.25,"price_display":"25.25","price_state":"stated","total_value":31082.75,"total_display":"31,082.75","total_whole":"31,083","shares_owned_after":38419.0,"shares_owned_after_display":"38,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-24","filed_date":"2008-06-26","scope":"insider"},{"id":9275880,"accession":"0001230295-08-000436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000436","line_url":"/filing/0001230295-08-000436#line-2","is_derivative":false,"issuer_cik":"0001364190","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0001364190","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.7502,"price_display":"25.75","price_state":"stated","total_value":128751.0,"total_display":"128,751.00","total_whole":"128,751","shares_owned_after":38419.0,"shares_owned_after_display":"38,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-23","filed_date":"2008-06-26","scope":"insider"},{"id":3772022,"accession":"0001230295-08-000432","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001230295-08-000432","line_url":"/filing/0001230295-08-000432#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.7502,"price_display":"25.75","price_state":"stated","total_value":128751.0,"total_display":"128,751.00","total_whole":"128,751","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-23","filed_date":"2008-06-23","scope":"insider"},{"id":9275881,"accession":"0001230295-08-000436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000436","line_url":"/filing/0001230295-08-000436#line-1","is_derivative":false,"issuer_cik":"0001364190","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0001364190","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1928.0,"shares_display":"1,928","price_per_share":24.893,"price_display":"24.89","price_state":"stated","total_value":47993.704,"total_display":"47,993.70","total_whole":"47,994","shares_owned_after":38419.0,"shares_owned_after_display":"38,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-26","scope":"insider"},{"id":3772018,"accession":"0001230295-08-000432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000432","line_url":"/filing/0001230295-08-000432#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1928.0,"shares_display":"1,928","price_per_share":24.893,"price_display":"24.89","price_state":"stated","total_value":47993.704,"total_display":"47,993.70","total_whole":"47,994","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":3649332,"accession":"0001230295-08-000437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000437","line_url":"/filing/0001230295-08-000437#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1232.0,"shares_display":"1,232","price_per_share":24.09,"price_display":"24.09","price_state":"stated","total_value":29678.88,"total_display":"29,678.88","total_whole":"29,679","shares_owned_after":38419.0,"shares_owned_after_display":"38,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-23","filed_date":"2008-06-26","scope":"insider"},{"id":3938723,"accession":"0001230295-08-000267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000267","line_url":"/filing/0001230295-08-000267#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":23.1741,"price_display":"23.17","price_state":"stated","total_value":110076.975,"total_display":"110,076.98","total_whole":"110,077","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-02","filed_date":"2008-05-06","scope":"insider"},{"id":3456980,"accession":"0001230295-08-000172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000172","line_url":"/filing/0001230295-08-000172#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2375.0,"shares_display":"2,375","price_per_share":22.78,"price_display":"22.78","price_state":"stated","total_value":54102.5,"total_display":"54,102.50","total_whole":"54,103","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-05","scope":"insider"},{"id":9275875,"accession":"0001230295-08-000142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000142","line_url":"/filing/0001230295-08-000142#line-1","is_derivative":false,"issuer_cik":"0001364190","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0001364190","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1636.0,"shares_display":"1,636","price_per_share":19.918,"price_display":"19.92","price_state":"stated","total_value":32585.848,"total_display":"32,585.85","total_whole":"32,586","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-15","filed_date":"2008-02-20","scope":"insider"},{"id":3456976,"accession":"0001230295-08-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000135","line_url":"/filing/0001230295-08-000135#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1636.0,"shares_display":"1,636","price_per_share":19.9192,"price_display":"19.92","price_state":"stated","total_value":32587.8112,"total_display":"32,587.81","total_whole":"32,588","shares_owned_after":39651.0,"shares_owned_after_display":"39,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-15","filed_date":"2008-02-20","scope":"insider"},{"id":3781811,"accession":"0001230295-08-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000078","line_url":"/filing/0001230295-08-000078#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2375.0,"shares_display":"2,375","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":47500.0,"total_display":"47,500.00","total_whole":"47,500","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-05","scope":"insider"},{"id":3625188,"accession":"0001230295-08-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000007","line_url":"/filing/0001230295-08-000007#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2375.0,"shares_display":"2,375","price_per_share":23.6,"price_display":"23.60","price_state":"stated","total_value":56050.0,"total_display":"56,050.00","total_whole":"56,050","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-02","filed_date":"2008-01-04","scope":"insider"},{"id":7481445,"accession":"0001230295-07-000781","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001230295-07-000781","line_url":"/filing/0001230295-07-000781#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":17.1193,"price_display":"17.12","price_state":"stated","total_value":57058.6269,"total_display":"57,058.63","total_whole":"57,059","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":7481441,"accession":"0001230295-07-000781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000781","line_url":"/filing/0001230295-07-000781#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.744,"price_display":"17.74","price_state":"stated","total_value":88720.0,"total_display":"88,720.00","total_whole":"88,720","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-13","filed_date":"2007-12-17","scope":"insider"},{"id":7306866,"accession":"0001230295-07-000750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-07-000750","line_url":"/filing/0001230295-07-000750#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2353.0,"shares_display":"2,353","price_per_share":15.2231,"price_display":"15.22","price_state":"stated","total_value":35819.9543,"total_display":"35,819.95","total_whole":"35,820","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-10","filed_date":"2007-12-12","scope":"insider"},{"id":7035688,"accession":"0001230295-07-000616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000616","line_url":"/filing/0001230295-07-000616#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":15.52,"price_display":"15.52","price_state":"stated","total_value":25871.84,"total_display":"25,871.84","total_whole":"25,872","shares_owned_after":43640.0,"shares_owned_after_display":"43,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-15","filed_date":"2007-10-17","scope":"insider"},{"id":7113471,"accession":"0001230295-07-000604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000604","line_url":"/filing/0001230295-07-000604#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.52,"price_display":"15.52","price_state":"stated","total_value":38800.0,"total_display":"38,800.00","total_whole":"38,800","shares_owned_after":43640.0,"shares_owned_after_display":"43,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-05","filed_date":"2007-10-09","scope":"insider"},{"id":8474364,"accession":"0001230295-07-000600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000600","line_url":"/filing/0001230295-07-000600#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.52,"price_display":"15.52","price_state":"stated","total_value":38800.0,"total_display":"38,800.00","total_whole":"38,800","shares_owned_after":43640.0,"shares_owned_after_display":"43,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-03","filed_date":"2007-10-05","scope":"insider"},{"id":7432754,"accession":"0001230295-07-000344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-07-000344","line_url":"/filing/0001230295-07-000344#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001364190","owner_name":"Hamelin Paul","owner_display_name":"Hamelin Paul","owner_url":"/insider/0001364190","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1220.0,"shares_display":"1,220","price_per_share":14.3488,"price_display":"14.35","price_state":"stated","total_value":17505.536,"total_display":"17,505.54","total_whole":"17,506","shares_owned_after":43640.0,"shares_owned_after_display":"43,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-23","filed_date":"2007-05-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (President)","n_filings":23,"first_seen":"2007-05-25","last_seen":"2011-02-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001364190","retrieved_at":"2026-08-25T09:26:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}